NCT02981108 2023-01-23A Study to Evaluate Safety, PK and Efficacy of HS-10296 in Patients With NSCLCJiangsu Hansoh Pharmaceutical Co., Ltd.Phase 1/2 Unknown364 enrolled 29 charts
NCT03849768 2023-01-20A Study to Evaluate Safety and Efficacy of HS-10296 as First-Line Treatment in PatientsJiangsu Hansoh Pharmaceutical Co., Ltd.Phase 3 Unknown429 enrolled 18 charts